Skip to main content
. Author manuscript; available in PMC: 2021 Jun 1.
Published in final edited form as: Surg Oncol. 2019 Jul 18;33:210–215. doi: 10.1016/j.suronc.2019.07.004

Table 2.

Studies of BRAF mutation in patients who underwent resection of colorectal liver metastases*

Reference Year No. of patients Frequency Multivariable analysis Association of BRAF mutation with prognosis
OS RFS
Gagniere et al.[27] 2018 1497 35 (2%) No Worse Worse
Margonis et al.[21] 2018 853 43 (5%) Yes Worse Worse

Abbreviations: OS, overall survival; RFS, recurrence-free survival.

*

More than 20 patients.

V600E BRAF vs. wild-type BRAF